These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 16395871
1. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. Int J Methods Psychiatr Res; 2005; 14(4):167-85. PubMed ID: 16395871 [Abstract] [Full Text] [Related]
3. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B. Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754 [Abstract] [Full Text] [Related]
5. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. Neuropsychopharmacology; 2007 Feb; 32(2):458-70. PubMed ID: 17077812 [Abstract] [Full Text] [Related]
7. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W. Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417 [Abstract] [Full Text] [Related]
13. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Vegting Y, Reneman L, Booij J. Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200 [Abstract] [Full Text] [Related]
14. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Lancet; 2001 Dec 01; 358(9296):1864-9. PubMed ID: 11741626 [Abstract] [Full Text] [Related]
15. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Neuropsychopharmacology; 2008 Jan 01; 33(2):247-58. PubMed ID: 17460617 [Abstract] [Full Text] [Related]
17. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study. Booij L, Soucy JP, Young SN, Regoli M, Gravel P, Diksic M, Leyton M, Pihl RO, Benkelfat C. J Neurochem; 2014 Dec 01; 131(5):634-44. PubMed ID: 25041501 [Abstract] [Full Text] [Related]
18. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M. Am J Psychiatry; 2004 Jul 01; 161(7):1181-9. PubMed ID: 15229049 [Abstract] [Full Text] [Related]
19. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Roiser JP, Rogers RD, Cook LJ, Sahakian BJ. Psychopharmacology (Berl); 2006 Oct 01; 188(2):213-27. PubMed ID: 16941121 [Abstract] [Full Text] [Related]